Clinical trials and rare diseases.

Area of Science:

• Clinical Trials
• Biostatistics
• Medical Research Methodology

Background:

• Standard statistical methods are preferred for clinical trials to ensure adequate informative value.
• Small clinical trials present unique challenges due to limited sample sizes.
• Alternative methodologies may be necessary when standard approaches are insufficient for small trials.

Purpose of the Study:

• To present basic concepts applicable to small clinical trials.
• To introduce specific methodological approaches for small clinical trials.
• To discuss strategies that enhance standard procedures or offer alternative paradigms.

Main Methods:

• Review of general concepts for small clinical trial design and analysis.
• Illustration of methods enhancing standard statistical procedures, including Bayesian adaptive randomization, group sequential designs, repeated measurements, and meta-analyses.
• Discussion of alternative strategies abandoning classical paradigms, such as risk-based allocation, statistical prediction, ranking and selection designs, and Bayesian statistics.

Main Results:

• Small trials, while valuable, cannot fully replace larger trials in terms of evidence.
• Several methodological approaches can improve the efficiency and informativeness of small clinical trials.
• Alternative statistical paradigms offer viable solutions for the unique challenges of small sample sizes.

Conclusions:

• Small clinical trials require specialized statistical considerations.
• Both enhanced standard methods and novel statistical paradigms can be effectively applied to small clinical trials.
• Careful selection of methodology is crucial for maximizing the value of small clinical trial data.